Uses of Lanlife

What is Lanlife drug? Lanlife medicine has the main active ingredient is Lansoprazole 30mg and other excipients in sufficient quantity. The dosage form of the drug is capsules, suitable for direct oral use. Packing is a box of 3 blisters and each blister contains 10 hard capsules. Lanlife belongs to the group of drugs that treat diseases of the gastrointestinal tract.
1.1. Pharmacodynamics of the active ingredient Lansoprazole Main active ingredient Lansoprazole is a potent inhibitor of acid secretion by inhibiting the enzyme H+,K+ ATPase activity in parietal cells of the gastric mucosa and plays an important role as a proton pump. Clinically, the active ingredient Lansoprazole achieves a fast and high healing rate against gastric ulcer and duodenal ulcer. The usefulness of the drug has been proven. In addition, this drug has also been shown to be effective in the treatment of reflux esophagitis and Zollinger-Ellison syndrome.
1.2. Pharmacokinetics of the active ingredient Lansoprazole Absorption: Lansoprazole is rapidly absorbed from the gastrointestinal tract, but varies depending on dose and gastric pH. Oral bioavailability can be as high as 70% with repeated administration. Distribution: The drug is strongly bound to plasma proteins. Metabolism: The drug is metabolized by the liver. Elimination ability: Active ingredient Lansoprazole is eliminated by the kidneys 80%, the average half-life is about 30-90 minutes. 1.3. The effect of the active ingredient Lansoprazole Active ingredient Lansoprazole inhibits H + / K + - ATPase. The drug causes specific and irreversible inhibition of the proton pump due to its selective effect on gastric parietal cells, so it acts faster and more effectively than other drugs. The rate of scar or ulcer healing can reach 95% after 8 weeks of treatment.
The drug has little effect on gastric juice volume, pepsin secretion, gastric endogenous factor and gastric contractility.

Lanlife medicine is used in the treatment of specific diseases as follows:
Treatment of ulcers of the stomach, duodenum and esophagus. Treatment of gastroesophageal reflux disease. Treatment of Zollinger-Ellison syndrome.

3.1. How to use Lanlife Lanlife medicine is prepared in the form of hard capsules containing Lansoprazole microparticles coated in the intestine, suitable for direct oral use. You should take the medicine in the morning before eating, do not break or chew the tablet when using. 3.2. Dosage of the drug Lanlife Dosage of the drug Lanlife, patients refer to the following:
The usual dose for adults is 30mg/day. Dosage for duodenal ulcer treatment lasts for 4 weeks. Dosage for treatment of peptic ulcer - oesophagitis lasts for a period of 8 weeks. Dosage for the treatment of gastroesophageal reflux - esophageal reflux is used for a period of 4 to 8 weeks. Zollinger-Ellison syndrome: Adjust dose according to symptoms.

During the use of Lanlife, users may experience some unwanted reactions to the body, including:
Hypersensitivity reactions: Rash and itching may occasionally appear. In this case, the drug containing the active ingredient Lansoprazole should be discontinued. Liver: Caused by an infrequent increase in SGOT, SGPT, Phosphatase-Alkaline, LDH or G-GTP, it should be closely monitored. If abnormalities appear, Lantazolin should be discontinued. Blood: Anemia, decreased white blood cell count, or increased eosinophil count may occur sporadically, decreased platelet count rarely occurs. Digestive system: Occasionally, gastrointestinal disturbances, constipation, diarrhea, dry mouth or abdominal distension may occur. Nervous system: Headache and somnolence may occur infrequently, while insomnia and dizziness are rare. Other undesirable effects such as fever or elevation of total cholesterol and uric acid have occasionally occurred.

Interactions of Lanlife drugs may occur during use. Therefore, attention should be paid to the following interactions so as not to reduce the therapeutic effect of the drug.
Do not use Lanlife with drugs that are metabolised by cytochrome P450. Lanlife reduces the effect of Ketoconazole and other drugs whose absorption requires an acidic environment. Sucralfate slows and reduces the absorption of the main active ingredient Lansoprazole.

In the process of using Lanlife, patients need to pay attention to the following issues:
6.1. Contraindications of the drug Lanlife Contraindications of the drug Lanlife in the following cases:
People with sensitive or sensitive physical conditions to the ingredients of the drug. Patients with malignant peptic ulcer disease. Use with caution in pregnant and lactating women. 6.2. Cautions and precautions of Lanlife drug Use caution when using Lanlife for children, pregnant women, lactating women, people with liver failure. During treatment, the treating doctor will assign careful monitoring of the disease status for each specific person. Lanlife should not be used in maintenance therapy if there is insufficient experience with long-term use. Medicines containing the active ingredient Lansoprazole should be used with caution in people with a history of drug sensitivity, liver dysfunction, and the elderly. Use in children: The safety of Lansoprazole in children has not been established (clinical trials are limited). Use in the elderly: Because the secretion of gastric acid and other physiological functions has decreased in the elderly, Lanlife should be used with caution. For pregnant and lactating women: When experiments were performed on rats, the concentration of lansoprazole in the embryonic serum was higher than in the maternal rat. For rabbits (30mg/kg oral dose) increased embryonic mortality. Therefore, Lanlife should not be used in women who are pregnant and suspected of being pregnant, unless it is truly beneficial. Currently, there have been reports in animal studies that the active ingredient Lansoprazole is excreted in human milk. Therefore, Lanlife should be avoided during lactation. However, you should only use the drug in cases where it is absolutely necessary after the treating doctor has weighed the benefits and possible risks to the baby's health. At the same time, the mother also needs to stop breastfeeding. Store Lanlife in a dry place, away from direct light. In addition, it is necessary to keep Lanlife medicine out of the reach of children and family pets. Absolutely do not use Lanlife after the expiry date.
Lanlife medicine has the main active ingredient is Lansoprazole 30mg and other excipients in a sufficient amount. Lanlife belongs to the group of drugs that treat diseases of the gastrointestinal tract. When prescribed by a doctor, patients should carefully read the instructions for use, consult a doctor / pharmacist before using the drug. Absolutely do not arbitrarily buy Lanlife medicine to treat diseases at home because there may be unwanted side effects on health.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.